Study examines new approach to detecting type 1 diabetes using a single blood draw

As part of a study in Diabetologia, researchers analyzed the data of four distinct studies of patients in the first and second stages of type 1 diabetes.

The participants were between the ages of 2 and 45. The oral glucose tolerance tests of more than 3,000 people were assessed.

According to the findings: “Our aim was to develop and validate a simpler tool based on a single blood draw.”

“Prediction models based on a single oral glucose tolerance test blood draw accurately predict disease progression from stage 1 or 2 to stage 3 type 1 diabetes,” the findings determined.

“The operational simplicity of M120, its validity across different at-risk populations and the requirement for 120 min sampling to stage type 1 diabetes suggest M120 could be readily applied to decrease the cost and complexity of risk stratification.”

The study was published online in August of 2021.

Image courtesy of Getty Images
More Stories
An early study of coronavirus cases finds neurologic manifestations in Chinese patients